Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc > THERA attracted professional fund(s) interests

<< Previous

Bullboard Posts

Next >>

Comment by qwerty22on Jul 24, 2020 12:04pm

118 Views

Post# 31314614

RE:THERA attracted professional fund(s) interests

Idk, could just be an over-reaction in after hours trading, my understanding is things get a lot more volatile when there are limited opportunities to trade after-hours.

JayjayUSA12007 wrote:
More than 4 mil shares traded since after-hour yesterday. Share price increased 45% during AH yesterday, but only 5% during normal hour today.
This is serious, professional work of price control for the purpose of accumulation. I don't think a bunch of Robinhood traders are behind this: very organized and coordinated work.

<< Previous

Bullboard Posts

Next >>

Increasing summer travel could see these airline stocks soar